Long Term Clinical Outcomes in Patients with Moderate Aortic Stenosis

The Moderate Aortic Stenosis Requiring Early Intervention

Authors

  • Han-Joon Bae, MD, PhD Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea
  • Jongmin Hwang, MD, PhD Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea https://orcid.org/0000-0001-9710-0945
  • Seongwook Han, MD, PhD Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea https://orcid.org/0000-0002-0496-7249
  • Seung-Ho Hur, MD, PhD Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea https://orcid.org/0000-0002-3895-1915
  • Jin-Wook Chung, MD, PhD Division of Cardiology, Department of Internal Medicine, Keimyung University Daegu Dongsan Hospital, Daegu, Republic of Korea
  • Hyungseop Kim, MD, PhD Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea http://orcid.org/0000-0001-7056-4221

DOI:

https://doi.org/10.1532/hsf.2971

Keywords:

Aortic stenosis, Diabetes, Echocardiography, Mitral regurgitation

Abstract

Background: While the surgical correction of moderate aortic stenosis (AS) can be deferred with a watchful waiting according to the present guideline, the clinical outcomes for moderate AS with comorbidity have not extensively been studied. We aimed to explore the factors that would contribute to the outcomes of moderate AS with at least five years of follow-up duration.

Methods: Medical records review identified patients with moderate aortic valve (AV) stenosis from January 2008 and December 2012. Echocardiographic data were gathered, and the final 5-year clinical outcomes, defined as the composite of cardiovascular (CV) death, admission for heart failure (HF) aggravation, and AV replacement, were evaluated.

Results: Among 148 patients (mean age, 69.3 years; mean AV area, 1.24 cm2), 79 had adverse outcomes (16 CV deaths, 32 AV replacements, and 31 HF cases), during a mean follow-up of 5.6 years. The event group showed worse dyspnea of NYHA III-IV and a higher frequency of diabetes mellitus (DM). They had a higher frequency of moderate or moderate-to-severe functional mitral regurgitation (MR) and smaller AV area. In the multivariate analysis, DM (HR 2.29, 95% CI 1.03-5.10), moderate or moderate-to-severe MR (HR 4.84, 95% CI 1.66-10.07), and NYHA III-IV (HR 3.84, 95% CI 1.72-8.56) independently were associated with adverse outcomes.

Conclusions: The symptomatic patients with moderate AS had higher events than expected, and early intervention should be considered in case of concomitant MR and DM.

References

Ahmed MI, Gladden JD, Litovsky SH, Lloyd SG, Gupta H, Inusah S, et al. 2010. Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction > 60%. J Am Coll Cardiol 55:671-679.

Bahler RC, Hawi R, Rovner A, Finkelhor RS, Thomas CL, Dawson NV. 2018. Predicting Outcomes in Patients With Asymptomatic Moderate to Severe Aortic Stenosis. Am J Cardiol 122:851-858.

Banovic M, Brkovic V, Nedeljkovic I, Popovic D, Djordjevic-Dikic A, Ristic A, et al. 2016. Diabetes mellitus and coronary microvascular function in asymptomatic patients with severe aortic stenosis and nonobstructed coronary arteries. Diab Vasc Dis Res 13:220-227.

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, et al. 2017. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739-2791.

Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, 2017. Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 30:372-392.

Benfari G, Nistri S, Faggiano P, Clavel MA, Maffeis C, Enriquez-Sarano M, et al. 2018. Mitral Effective Regurgitant Orifice Area Predicts Pulmonary Artery Pressure Level in Patients with Aortic Valve Stenosis. J Am Soc Echocardiogr 31:570-577.

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 37:2999-3058.

Clark TG, Altman DG, De Stavola BL. 2002. Quantification of the completeness of follow-up. Lancet 359:1309–10.

El Sabbagh A, Reddy YNV, Nishimura RA. 2018. Mitral Valve Regurgitation in the Contemporary Era: Insights Into Diagnosis, Management, and Future Directions. JACC Cardiovasc Imaging 11:628-643.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. 2015. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233-270.

Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. 2016. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17:1321-1360.

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 70:252-289.

Passik CS, Ackerann DM, Pluth JR, Edwards WD. 1987. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc 62:119-123.

Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, et al. 2012. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 33:822-828.

Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, et al. 2004. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 25:199-205.

Sehovic S, Talic A, Kacila M, Tahirovic E. 2015. The Influence of Aortic Valve Replacement on Functional Moderate - To-Severe Mitral Regurgitation in Patients with Aortic Valve Stenosis. Acta Inform Med 23:147-150.

Spitzer E, Van Mieghem NM, Pibarot P, Hahn RT, Kodali S, Maurer MS, et al. 2016. Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. Am Heart J 182:80-88.

Unger P, Plein D, Van Camp G, Cosyns B, Pasquet A, Henrard V, et al. 2008. Effects of Valve Replacement for Aortic Stenosis on Mitral Regurgitation. Am J Cardiol 102:1378-1382.

van Gils L, Clavel MA, Vollema EM, Hahn RT, Spitzer E, Delgado V, et al. 2017. Prognostic Implications of Moderate Aortic Stenosis in Patients With Left Ventricular Systolic Dysfunction. J Am Coll Cardiol 69:2383-2392.

Yechoor P, Blaustein AS, Bakaeen FG, Cornwell LD, Coselli JS, LeMaire SA, et al. The natural history of moderate aortic stenosis in a veteran population. J Thorac Cardiovasc Surg 145:1550-1553.

Published

2020-05-28

How to Cite

Bae, H. J., Hwang, J., Han, S., Hur, S.-H., Chung, J.-W., & Kim, H. (2020). Long Term Clinical Outcomes in Patients with Moderate Aortic Stenosis: The Moderate Aortic Stenosis Requiring Early Intervention. The Heart Surgery Forum, 23(3), E358-E365. https://doi.org/10.1532/hsf.2971

Issue

Section

Article